Pembrolizumab for Newly Diagnosed Glioblastoma
Clinical trial NCT03899857 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03899857
- Sponsor
- University of Zurich
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2026-04-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.